tirzepatide patient assistance programs program eli lilly Financial Assistance Options Zepbound Patient Assistance Program: The – Eli Lilly's Zepbound Becomes First – Savings & Support with Lilly

Helping your cells produce new DNA, which is necessary for cell division, tissue growth, and repair

Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake

Regular check-ins with a healthcare provider help track metabolic health, adjust lifestyle strategies, and determine whether medication should be restarted or adjusted

Every needle puncture introduces potential contamination to the stopper surface

[PMID: 30585609] PubMed record related to this compound for laboratory literature review

Market Size & Growth Forecasts The global GLP-1 analogues market is estimated at $66.48 billion in 2025, projected to skyrocket to $879.9 billion by 2034, representing an impressive CAGR of ~33.2% Another source estimates the broader GLP-1 market at $47.74 billion in 2024, with a more conservative CAGR of 10.9% from 20252034